| Issue |
Section |
Title |
File |
| Vol 18, No 3 (2021) |
Clinical practice guidelines |
Atopic dermatitis |
(Rus)
|
| Vol 18, No 3 (2021) |
Clinical practice guidelines |
Vaccination against COVID-19 for patients with primary immunodeficiency and hereditary angioedema: the position paper of the Russian Association of Allergology, Clinical Immunology, and the National Association of Experts in Primary Immunodeficiencies |
(Rus)
|
| Vol 18, No 3 (2021) |
Letters to the editor |
Long-term prophylaxis therapy in patients with hereditary angioedema in Russia: resolution of the expert Council |
(Rus)
|
| Vol 18, No 4 (2021) |
Clinical practice guidelines |
Asthma |
(Rus)
|
| Vol 19, No 4 (2022) |
Original studies |
Efficacy and predictors of rapid response to omalizumab therapy in patients with seasonal allergic rhinitis: a cohort study |
(Rus)
|
| Vol 19, No 3 (2022) |
Original studies |
Epidemiology of chronic inducible urticaria in Moscow |
(Rus)
(Eng)
|
| Vol 20, No 1 (2023) |
Reviews |
Chronic-induced urticaria; classification, actual aspects of diagnosis and therapy |
(Rus)
(Eng)
|
| Vol 20, No 1 (2023) |
Original studies |
Cholinergic urticaria: search for predictors of course severity and response to therapy |
(Rus)
|
| Vol 20, No 2 (2023) |
Original studies |
Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation |
(Rus)
(Eng)
|
| Vol 20, No 4 (2023) |
Original studies |
Clinical predictors of antihistamine resistance in patients with chronic spontaneous urticaria |
(Rus)
|
| Vol 20, No 2 (2023) |
Case reports |
Myoferline gene mutation сan be associated with recurrent angioedema |
(Rus)
|
| Vol 20, No 3 (2023) |
Original studies |
Comparative analysis of clinical efficacy and safety of omalizumab biosimilar in the treatment of patients with chronic spontaneous urticaria |
(Rus)
|
| Vol 21, No 1 (2024) |
Original studies |
Analysis of the sensitization spectrum in patients with severe allergic diseases using the ImmunoCAP ISAC method |
(Rus)
|
| Vol 21, No 2 (2024) |
Original studies |
New coronavirus infection SARS-CoV-2 in adult patients with inborn errors of immunity |
(Rus)
|
| Vol 21, No 1 (2024) |
Original studies |
Clinical-anamnestic analysis of patients diagnosed as "Anaphylaxis" hospitalized in Moscow medical hospitals |
|
| Vol 21, No 1 (2024) |
Original studies |
Analysis of patients with cold urticaria in the context of typical and atypical forms |
(Rus)
|
| Vol 21, No 1 (2024) |
Clinical practice guidelines |
Urticaria |
(Rus)
|
| Vol 21, No 4 (2024) |
Original studies |
Subcutaneous immunoglobulin 16.5 % given by the rapid push method in patients with inborn errors of immunity: a prospective multicenter study of quality of life |
|
| Vol 22, No 2 (2025) |
Case reports |
Vasculitis with nervous system damage in a patient with adenosine deaminase 2 deficiency |
(Rus)
|
